Evidence map›Paper›PMID 23893127›Full record

ReviewBreast cancer research and treatment2013

Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research.

Michaela S Tracy, Shoshana M Rosenberg, Laura Dominici, Ann H Partridge

Abstract readReview
In one paragraph

Review in Breast cancer research and treatment, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Controversies in Breast Cancer Surgery.The Surgical clinics of North America · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Patient-Reported Outcomes 1 Year After Immediate Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2017
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michaela S TracyDana-Farber Cancer Institute, Brigham and Women's Hospital, 450 Brookline Ave Boston, Boston, MA 02215, USA.
Shoshana M Rosenberg
Laura Dominici
Ann H Partridge

Funding

Harvard Education Program in Cancer Prevention Control (R25T)R25CA057711 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI DAVISON, KIRSTEN · 1992 to 2018
$8.5M
NCI NIH HHS 5 R25 CA057711NCI NIH HHS R25 CA057711
6 · The paper itself

Abstract

Recent studies have revealed increasing rates of contralateral prophylactic mastectomy (CPM) among women with unilateral early stage breast cancer. This trend has raised concerns, given the lack of evidence for a survival benefit from CPM and the relatively low risk of contralateral breast cancer for most women in this setting. In this article, we review available data regarding the value of CPM, predictors, and outcomes related to CPM, and areas for future research and potential intervention.

Indexed as

Breast NeoplasmsFemaleHumansMastectomyPatient SatisfactionTreatment Outcome

Identifiers

PMID23893127
PMCPMC3860879

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.